TrialClinical rheumatology2016

A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate.

Xiao-Xiang Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.